This year, Jeremy Farrar is one of our key note speakers.

jeremy farrarJeremy Farrar is director of the Wellcome Trust, an independent British charitable foundation that persues a better health worldwide. Before joining Wellcome in October 2013, Jeremy was Director of the Oxford University Clinical Research Unit in Vietnam for 18 years. His research interests were infectious diseases, tropical health and emerging infections. He has published over 500 peer-reviewed scientific papers, mentored many dozens of students and fellows, and served as Chair on several advisory boards for governments and global organisations, including the World Health Organization. He was named 12th in Fortune's list of the World's 50 Greatest Leaders in 2015.

Jeremy was appointed OBE in 2005 for services to tropical medicine, was awarded the Memorial Medal and the Ho Chi Minh City Medal by the Government of Vietnam, and has been honoured by the Royal College of Physicians in the UK and the American Society for Tropical Medicine and Hygiene. He is a Fellow of both the Academy of Medical Sciences and the Royal Society.

Thursday June 6

Alan Karthikesalingam 246

Dr Alan Karthikesalingam - "Applying machine learning to healthcare"

Alan Karthikesalingam is a senior clinician scientist at DeepMind Health, leading the translation between our Health Research and Streams teams. He is responsible for ensuring the clinical focus of our health research; the prototyping of ML algorithms into devices subject to clinical effectiveness studies; and leads our clinical trials and evaluation across both Research and Streams.

After studying medicine at the University of Cambridge, Alan trained in vascular and endovascular surgery in London, Lille and New York. At St George’ s University of London, he completed his PhD and led a successful research group investigating neural networks for medical imaging, new approaches to registry-based randomised trials, the use of routine data to understand care outcomes and international comparisons of cardiovascular care.

Alongside clinical practice he published over 125 peer-reviewed papers, including award-winning first-author studies in the Lancet and the New England Journal of Medicine. His work supported the centralisation of vascular services in the UK and he remains an honorary Reader (associate professor) at St George’ s, where he was appointed deputy head of the university vascular institute. Prior to joining DeepMind he co-launched an app still in use across the London Ambulance Service in a study of vascular emergency triage.

image001Professor Sir Peng Tee Khaw
PhD FRCS FRCP FRCOphth FRCPath FRSB FCOptom (Hon) DSc FARVO FMedSci

Professor of Glaucoma and Ocular Healing and Consultant Ophthalmic Surgeon.
Director of the NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Research and Development, Moorfields Eye Hospital and; Eyes and Vision Programme, UCL Partners Academic Health Science Centre.

Sir Peng’s research interests are in developing new therapies, particularly for preventing scarring and regeneration, with a special interest in paediatric and young adult glaucoma. He has developed surgical techniques including the Moorfields Safer Surgery System, which have markedly improved the safety and outcomes of antimetabolite-assisted trabeculectomy in many parts of the world, especially reducing bleb related endophthalmitis and blebitis. He has developed anti-scarring regimens, which have led to international clinical trials. Currently, he is developing new anti-scarring drugs and delivery system, as well as devices, and has proposed the 10-10-10 challenge for glaucoma around the world: an intraocular pressure of 10 mmHg for 10 years done in 10 minutes. He has also published the ‘energy’ theory of glaucomatous axonopathy, helping move towards stem cell regenerative therapies for the optic nerve.

His publications include over 450 papers, chapters and books, and has helped raise over £120 million for clinical and research facilities, including the world’s largest children’s eye hospital. He was the first British President of ARVO and with his group has won some 25 awards, which include the first international ARVO/Pfizer Ophthalmic Translational Research Award; Alcon Research Institute Award; Sir Stewart Duke Elder Lecture & Medal Royal College of Ophthalmologists; 12th Lang Lecture Medal Royal Society of Medicine; the 23rd Dame Ida Mann Lecture Oxford University; and Hunterian Professorship at the Royal College of Surgeons of England.

Sir Peng was knighted in 2013 for services to ophthalmology by Her Majesty Queen Elizabeth II.